Evaluation of hepatitis C virus RNA RT/PCR qualitative and quantitative second generation assays

Journal of Virological Methods

Volumn 91, Issue 1, 2001, Pages 51-58

  Castro, F J ^a   Sauleda, S ^a   Esteban, J I ^a   Viladomiu, L ^a   Martell, M ^a   Dragon, E ^a   Esteban, R ^a   Guardia, J ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

HCV RNA; Hepatitis C; RT PCR

Indexed keywords

VIRUS RNA;

ACCURACY; ADULT; ARTICLE; ASSAY; CONTROLLED STUDY; EVALUATION; FEMALE; GENOTYPE; HEPATITIS C VIRUS; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; VIREMIA;

ADULT; BLOOD DONORS; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY;

EID: 0035147229     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(00)00243-3     Document Type: Article

References (20)

1. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis
2. Utility of early testing for HCV viremia as predictive factor of sustained response during interferon or interferon plus ribavirin treatment
3. Isolation of a cDNA clone derived from a blood-born non-A, non-B viral hepatitis genome
4. Development of a quantitative PCR assay for monitoring HCV viremia levels in patients with chronic hepatitis C
5. Accurate identification of Hepatitis C Virus (HCV) RNA from all HCV genotypes by using branched-DNA Technology
6. Long-term clinical and histopathological follow-up of chonic post-transfusion hepatitis
7. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus
8. Comparison of plasma virus load among individuals infected with hepatitis C virus (HCV) genotypes 2 and 3 by Quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and in-house limiting dilution method
9. The treatment of chronic viral hepatitis
10. An assay for circulating antibodies to a major etiologic agent of human non-A, non-B hepatitis
11. High throughput real-time RT-PCR quantitation of hepatitis C virus RNA
12. Pretreatment HCV RNA levels and HCV genotype are the main and independent prognostic factors of sustained response to α interferon therapy in chronic hepatitis C
13. A new step toward standardization of serum hepatitis C virus-RNA quantification in patients with chronic hepatitis C
14. Is there an optimal time to measure quantitative HCV RNA to predict outcome following interferon treatment for chronic HCV infection
15. Factors affecting treatment responses to interferon-α in chronic hepatitis C
16. Randomized trial on interferon α-2b plus rivabirin for 48 weeks or for 24 weeks versus interferon α-2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
17. Is an 'À la carte' combination interferon α-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C
18. Hepatitis C in patients undergoing liver transplantation
19. Comparison of two quantitative hepatitis C virus reverse transcriptase PCR assays
20. Treatment with Interferon plus Ribavirin in anti-HIV negative patients with congenital coagulation disorders and chronic hepatitis C